295 related articles for article (PubMed ID: 31160781)
1. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O
Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781
[TBL] [Abstract][Full Text] [Related]
2. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
Yan R; Zhao X; Lei J; Zhou Q
Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
[TBL] [Abstract][Full Text] [Related]
3. LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM.
Chiduza GN; Johnson RM; Wright GSA; Antonyuk SV; Muench SP; Hasnain SS
Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):660-669. PubMed ID: 31282475
[TBL] [Abstract][Full Text] [Related]
4. Consensus mutagenesis approach improves the thermal stability of system x
Oda K; Lee Y; Wiriyasermkul P; Tanaka Y; Takemoto M; Yamashita K; Nagamori S; Nishizawa T; Nureki O
Protein Sci; 2020 Dec; 29(12):2398-2407. PubMed ID: 33016372
[TBL] [Abstract][Full Text] [Related]
5. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer.
Ichinoe M; Mikami T; Yanagisawa N; Yoshida T; Hana K; Endou H; Okayasu I; Sengoku N; Ogata H; Saegusa M; Shibuya K; Murakumo Y
J Clin Pathol; 2021 Sep; 74(9):589-595. PubMed ID: 32907912
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of CD98 heavy chain and L-type amino acid transporter 1 and its prognostic significance in colorectal cancer.
Lee D; Kim HS; Kim HU; Song HJ; Lee C; Kim DY; Chun HM; Jang WY; Jang B
Pathol Res Pract; 2022 Jan; 229():153730. PubMed ID: 34942513
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells.
Le Vee M; Jouan E; Lecureur V; Fardel O
Toxicol Appl Pharmacol; 2016 Jan; 290():74-85. PubMed ID: 26621329
[TBL] [Abstract][Full Text] [Related]
9. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
[TBL] [Abstract][Full Text] [Related]
10. Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
Jeckelmann JM; Fotiadis D
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795505
[TBL] [Abstract][Full Text] [Related]
11. CD98 increases renal epithelial cell proliferation by activating MAPKs.
Bulus N; Feral C; Pozzi A; Zent R
PLoS One; 2012; 7(6):e40026. PubMed ID: 22768207
[TBL] [Abstract][Full Text] [Related]
12. Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B
Taslimifar M; Faltys M; Kurtcuoglu V; Verrey F; Makrides V
J Cereb Blood Flow Metab; 2022 Jan; 42(1):90-103. PubMed ID: 34427144
[TBL] [Abstract][Full Text] [Related]
13. Insights into L-type heteromeric amino acid transporters.
Newstead S
Nat Struct Mol Biol; 2019 Jun; 26(6):395-396. PubMed ID: 31160779
[No Abstract] [Full Text] [Related]
14. The structure of the human 4F2hc-LAT1 heteromeric amino acid transporter.
Fotiadis D; Jeckelmann JM
Sci China Life Sci; 2019 Jun; 62(6):848-850. PubMed ID: 31076972
[No Abstract] [Full Text] [Related]
15. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
[TBL] [Abstract][Full Text] [Related]
16. LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter.
Napolitano L; Scalise M; Galluccio M; Pochini L; Albanese LM; Indiveri C
Int J Biochem Cell Biol; 2015 Oct; 67():25-33. PubMed ID: 26256001
[TBL] [Abstract][Full Text] [Related]
17. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications.
Kahlhofer J; Teis D
Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):459-472. PubMed ID: 36460306
[TBL] [Abstract][Full Text] [Related]
18. Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol.
Dickens D; Chiduza GN; Wright GS; Pirmohamed M; Antonyuk SV; Hasnain SS
Sci Rep; 2017 Mar; 7():43580. PubMed ID: 28272458
[TBL] [Abstract][Full Text] [Related]
19. Drosophila expresses a CD98 transporter with an evolutionarily conserved structure and amino acid-transport properties.
Reynolds B; Roversi P; Laynes R; Kazi S; Boyd CA; Goberdhan DC
Biochem J; 2009 May; 420(3):363-72. PubMed ID: 19335336
[TBL] [Abstract][Full Text] [Related]
20. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
Lu X
Curr Cancer Drug Targets; 2019; 19(11):863-876. PubMed ID: 31376820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
